How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

2,977 results for

Long-Acting Reversible Contraception

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

181. Reductions in pregnancy rates in the USA with long-acting reversible contraception: a cluster randomised trial. (PubMed)

Reductions in pregnancy rates in the USA with long-acting reversible contraception: a cluster randomised trial. Unintended pregnancy remains a serious public health challenge in the USA. We assessed the effects of an intervention to increase patients' access to long-acting reversible contraceptives (LARCs) on pregnancy rates.We did a cluster randomised trial in 40 reproductive health clinics across the USA in 2011-13. 20 clinics were randomly assigned to receive evidence-based training (...) per 100 person-years), but not after abortion visits (26·5 vs 22·3 per 100 person-years). We found a significant intervention effect on pregnancy rates in women attending family planning visits (hazard ratio 0·54, 95% CI 0·34-0·85).The pregnancy rate can be reduced by provision of counselling on long-term reversible contraception and access to devices during family planning counselling visits.William and Flora Hewlett Foundation.Copyright © 2015 Elsevier Ltd. All rights reserved.

2015 Lancet (London, England) Controlled trial quality: predicted high

182. Barriers to Receiving Long-acting Reversible Contraception in the Postpartum Period. (PubMed)

Barriers to Receiving Long-acting Reversible Contraception in the Postpartum Period. To assess why postpartum women who desired long-acting reversible contraception (LARC) did not receive it in the postpartum period and to assess which contraceptive methods they were using instead.This was a subgroup analysis of 324 women enrolled in a randomized, controlled trial to receive or not receive an educational LARC script during their postpartum hospitalization. Participants in this subgroup analysis (...) it in the postpartum period and used less effective contraceptive methods. Increasing access to immediate postpartum LARC and eliminating two-visit protocols for LARC insertion may increase postpartum LARC use. As the Affordable Care Act moves toward full implementation, it is necessary to understand the barriers that prevent interested patients from receiving LARC.Copyright © 2015 Jacobs Institute of Women's Health. Published by Elsevier Inc. All rights reserved.

2015 Women's health issues : official publication of the Jacobs Institute of Women's Health Controlled trial quality: uncertain

183. Immediate versus delayed postpartum insertion of contraceptive implant for contraception. (PubMed)

Immediate versus delayed postpartum insertion of contraceptive implant for contraception. The spacing of pregnancies has a positive impact on maternal and newborn health. The progestin contraceptive implant, which is a long-acting, reversible method of contraception, has a well-established low failure rate that is compatible with tubal sterilization. The standard provision of contraceptive methods on the first postpartum visit may put some women at risk of unintended pregnancy, either due (...) to loss to follow-up or having sexual intercourse prior to receiving contraception. Therefore, the immediate administration of contraception prior to discharge from the hospital that has high efficacy may improve contraceptive prevalence and prevent unintended pregnancy.To compare the initiation rate, effectiveness, and side effects of immediate versus delayed postpartum insertion of implant for contraception.We searched for eligible studies up to 28 October 2016 in the Cochrane Central Register

Full Text available with Trip Pro

2017 Cochrane

184. Efficacy, Safety and Tolerability Study of Long-acting Cabotegravir Plus Long-acting Rilpivirine (CAB LA + RPV LA) in Human-immunodeficiency Virus-1 (HIV-1) Infected Adults

: No Keywords provided by ViiV Healthcare: Long acting Cabotegravir Safety HIV-1 Efficacy Tolerability ATLAS-2M Long acting Rilpivirine Additional relevant MeSH terms: Layout table for MeSH terms HIV Infections Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases Rilpivirine Reverse Transcriptase Inhibitors Nucleic Acid Synthesis Inhibitors Enzyme Inhibitors (...) Efficacy, Safety and Tolerability Study of Long-acting Cabotegravir Plus Long-acting Rilpivirine (CAB LA + RPV LA) in Human-immunodeficiency Virus-1 (HIV-1) Infected Adults Efficacy, Safety and Tolerability Study of Long-acting Cabotegravir Plus Long-acting Rilpivirine (CAB LA + RPV LA) in Human-immunodeficiency Virus-1 (HIV-1) Infected Adults - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information

2017 Clinical Trials

185. Patient Compliance With Long-Acting Reversible Contraception Administration

Patient Compliance With Long-Acting Reversible Contraception Administration Patient Compliance With Long-Acting Reversible Contraception Administration - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) . Patient Compliance With Long-Acting Reversible Contraception Administration The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03305081 Recruitment Status : Terminated First Posted : October 9, 2017 Last Update Posted : October 9, 2017 Sponsor: Tulane University School of Medicine Information provided

2014 Clinical Trials

186. Medicaid reimbursement for immediate post-abortion provision of long-acting reversible contraception reduces both unintended pregnancies and health care expenditures. (PubMed)

Medicaid reimbursement for immediate post-abortion provision of long-acting reversible contraception reduces both unintended pregnancies and health care expenditures. 25108581 2015 05 21 2018 12 02 1879-0518 90 6 2014 Dec Contraception Contraception Medicaid reimbursement for immediate post-abortion provision of long-acting reversible contraception reduces both unintended pregnancies and health care expenditures. 616-7 10.1016/j.contraception.2014.05.020 S0010-7824(14)00351-5 Tsao Tsu-Yu TY (...) Hygiene. eng 5U58CD0001252-04 CD ODCDC CDC HHS United States Letter Research Support, U.S. Gov't, P.H.S. Comment 2014 06 26 United States Contraception 0234361 0010-7824 0 Contraceptive Agents, Female C2QI4IOI2G Medroxyprogesterone Acetate IM Contraception. 2014 Feb;89(2):103-8 24309218 Contraception. 2014 Dec;90(6):617 25217445 Abortion, Induced Contraceptive Agents, Female administration & dosage Female Humans Intrauterine Devices Medroxyprogesterone Acetate administration & dosage Pregnancy

2014 Contraception

187. Factors Influencing the Provision of Long-Acting Reversible Contraception in California. (PubMed)

Factors Influencing the Provision of Long-Acting Reversible Contraception in California. To assess long-acting reversible contraception (LARC) beliefs and practices among site directors who represent the family planning services delivered in their practices.Medical directors from 1,000 sites listed in the Family Planning Access Care and Treatment program (California's family planning Medicaid program) provider database were mailed a survey in the fall of 2011 regarding their LARC beliefs (...) /587). They were most likely to consider women with a history of pelvic inflammatory disease unsuitable for hormonal (27%, n=161) and copper (26%, n=154) intrauterine devices. Smokers were the most likely to be considered unsuitable for the implant (16%, n=96). Nearly three fourths of respondents routinely discussed intrauterine devices (413/561) and half (271/558) discussed implants with their contraceptive patients. Characteristics that predicted onsite LARC provision included LARC training

Full Text available with Trip Pro

2014 Obstetrics and Gynecology

188. Cost of unintended pregnancy in Norway: a role for long-acting reversible contraception. (PubMed)

Cost of unintended pregnancy in Norway: a role for long-acting reversible contraception. The objective of this study was to quantify the cost burden of unintended pregnancies (UPs) in Norway, and to estimate the proportion of costs due to imperfect contraceptive adherence. Potential cost savings that could arise from increased uptake of long-acting reversible contraception (LARC) were also investigated.An economic model was constructed to estimate the total number of UPs and associated costs (...) in women aged 15-24 years. Adherence-related UP was estimated using 'perfect use' and 'typical use' contraceptive failure rates. Potential savings from increased use of LARC were projected by comparing current costs to projected costs following a 5% increase in LARC uptake.Total costs from UP in women aged 15-24 years were estimated to be 164 million Norwegian Kroner (NOK), of which 81.7% were projected to be due to imperfect contraceptive adherence. A 5% increase in LARC uptake was estimated

Full Text available with Trip Pro

2014 Journal of Family Planning and Reproductive Health Care

189. Factors predicting uptake of long-acting reversible methods of contraception among women presenting for abortion. (PubMed)

Factors predicting uptake of long-acting reversible methods of contraception among women presenting for abortion. To examine the uptake of long-acting reversible contraceptive (LARC) methods after abortion among women seeking abortions through a major Australian abortion provider.Cross-sectional study of women's post-abortion contraceptive choices, conducted at Marie Stopes International clinics across Australia between 1 September and 31 December 2012.7267 of 9477 women (76.7%) presenting (...) during the study period had data collection forms completed. Analysis was based on the 6348 women with completed demographic details.Uptake and immediate provision of LARC contraception after abortion.Just over a quarter of women (1742; 27.4%) chose a LARC method for use after abortion. Of those choosing a LARC, immediate provision occurred in 71.1%. Compared with women aged 20-24 years, those aged 16-19 years were less likely to have immediate LARC insertion and those over 30 more likely. Women

2014 Medical Journal of Australia

190. Achieving cost-neutrality with long-acting reversible contraceptive methods. (PubMed)

Achieving cost-neutrality with long-acting reversible contraceptive methods. This analysis aimed to estimate the average annual cost of available reversible contraceptive methods in the United States. In line with literature suggesting long-acting reversible contraceptive (LARC) methods become increasingly cost-saving with extended duration of use, it aimed to also quantify minimum duration of use required for LARC methods to achieve cost-neutrality relative to other reversible contraceptive (...) methods while taking into consideration discontinuation.A three-state economic model was developed to estimate relative costs of no method (chance), four short-acting reversible (SARC) methods (oral contraceptive, ring, patch and injection) and three LARC methods [implant, copper intrauterine device (IUD) and levonorgestrel intrauterine system (LNG-IUS) 20 mcg/24 h (total content 52 mg)]. The analysis was conducted over a 5-year time horizon in 1000 women aged 20-29 years. Method-specific failure

Full Text available with Trip Pro

2014 Contraception

191. Association of short-term bleeding and cramping patterns with long-acting reversible contraceptive method satisfaction. (PubMed)

Association of short-term bleeding and cramping patterns with long-acting reversible contraceptive method satisfaction. We sought to examine the short-term (3- and 6-month), self-reported bleeding and cramping patterns with intrauterine devices (IUDs) and the contraceptive implant, and the association of these symptoms with method satisfaction.We analyzed 3- and 6-month survey data from IUD and implant users in the Contraceptive CHOICE Project, a prospective cohort study. Participants who (...) received a long-acting reversible contraceptive (LARC) method (levonorgestrel-releasing intrauterine system [LNG-IUS], copper IUD, or the etonogestrel implant) and completed their 3- and 6-month surveys were included. Univariable and multivariable analyses were performed to examine the association of bleeding and cramping patterns with short-term satisfaction.Our analytic sample included 5011 Contraceptive CHOICE Project participants: 3001 LNG-IUS users, 826 copper IUD users, and 1184 implant users

Full Text available with Trip Pro

2014 American Journal of Obstetrics and Gynecology

192. Roles of the Pharmacist in the Use of Safe and Highly Effective Long-Acting Reversible Contraception: An Opinion of the Women's Health Practice and Research Network of the American College of Clinical Pharmacy. (PubMed)

Roles of the Pharmacist in the Use of Safe and Highly Effective Long-Acting Reversible Contraception: An Opinion of the Women's Health Practice and Research Network of the American College of Clinical Pharmacy. The U.S. population continues to experience an alarmingly high rate of unintended pregnancies that have an impact on individual families and society alike. Lack of effective contraception accounts for most unintended pregnancies, along with incorrect use of contraceptives. The most (...) common reversible contraceptive method used in the United States is the oral contraceptive pill, which has significant failure and discontinuation rates. Use of long-acting reversible contraceptive (LARC) methods has been increasing in recent years after efforts to educate providers and patients. Women are more likely to use LARC methods when barriers such as access and cost are removed. An uptake in the use of LARC methods would allow for markedly reduced contraception failure rates and higher user

2014 Pharmacotherapy

193. Celebration Meets Caution: Long Acting Reversible Contraception (LARC)’s Boons, Potential Busts, and the Benefits of a Reproductive Justice Approach (PubMed)

Celebration Meets Caution: Long Acting Reversible Contraception (LARC)’s Boons, Potential Busts, and the Benefits of a Reproductive Justice Approach 24582293 2014 11 21 2018 11 13 1879-0518 89 4 2014 Apr Contraception Contraception Celebration meets caution: LARC's boons, potential busts, and the benefits of a reproductive justice approach. 237-41 10.1016/j.contraception.2014.01.027 S0010-7824(14)00038-9 Higgins Jenny A JA University of Wisconsin, Madison, WI 53706, USA. Electronic address (...) : jahiggins2@wisc.edu. eng K12 HD055894 HD NICHD NIH HHS United States P2C HD047873 HD NICHD NIH HHS United States K12HD055894 HD NICHD NIH HHS United States Journal Article Research Support, N.I.H., Extramural 2014 02 10 United States Contraception 0234361 0010-7824 0 Contraceptive Agents, Female IM Contraception ethics psychology trends Contraceptive Agents, Female administration & dosage Female Humans Intrauterine Devices Social Justice 2014 01 22 2014 01 31 2014 3 4 6 0 2014 3 4 6 0 2014 12 15 6 0

Full Text available with Trip Pro

2014 Contraception

194. Long-Acting Reversible Contraceptive Use in Urban Women From a Title X–Supported Boston Community Health Center (PubMed)

Long-Acting Reversible Contraceptive Use in Urban Women From a Title X–Supported Boston Community Health Center Unintended and adolescent pregnancy disproportionately affects minority populations, but the effect of age, race and ethnicity on the use of long-acting reversible contraception (LARC) has not been well studied.The objective of this pilot study was to examine LARC use over a 5-year period among women receiving care at a Boston community health center.Retrospective cohort study (...) of LARC method use among black, Hispanic, and white women receiving care at the Dimock Center from 2006 to 2010.This study included 276 women (60.1% black, 18.5% Hispanic, and 9.1% white). LARC was not used as a first-line method in the majority (96.0%), regardless of age, race, and ethnicity; yet nearly half identified a long-acting contraceptive as their method of choice.The findings of this pilot study reveal opportunities to reduce unintended pregnancy through increased LARC use, which may

Full Text available with Trip Pro

2014 Journal of primary care & community health

195. Impact of pay for performance on prescribing of long-acting reversible contraception in primary care: an interrupted time series study. (PubMed)

Impact of pay for performance on prescribing of long-acting reversible contraception in primary care: an interrupted time series study. The aim of this study was to evaluate the impact of Quality and Outcomes Framework (QOF), a major pay-for-performance programme in the United Kingdom, on prescribing of long-acting reversible contraceptives (LARC) in primary care.Negative binomial interrupted time series analysis using practice level prescribing data from April 2007 to March 2012. The main (...) outcome measure was the prescribing rate of long-acting reversible contraceptives (LARC), including hormonal and non hormonal intrauterine devices and systems (IUDs and IUSs), injectable contraceptives and hormonal implants.Prescribing rates of Long-Acting Reversible Contraception (LARC) were stable before the introduction of contraceptive targets to the QOF and increased afterwards by 4% annually (rate ratios  = 1.04, 95% CI = 1.03, 1.06). The increase in LARC prescribing was mainly driven

Full Text available with Trip Pro

2014 PloS one Controlled trial quality: uncertain

196. Impact of a theory-based video on initiation of long-acting reversible contraception postabortion. (PubMed)

Impact of a theory-based video on initiation of long-acting reversible contraception postabortion. Adoption of long-acting reversible contraception (LARC) (ie, the intrauterine device or the contraceptive implant) immediately after abortion is associated with high contraceptive satisfaction and reduced rates of repeat abortion. Theory-based counseling interventions have been demonstrated to improve a variety of health behaviors; data on theory-based counseling interventions for postabortion (...) contraception are lacking.Informed by the transtheoretical model of behavioral change, a video intervention was developed to increase awareness of, and dispel misconceptions about, LARC methods. The intervention was evaluated in a randomized controlled trial among women aged 18-29 years undergoing surgical abortion at a clinic in Chicago, IL. Participants were randomized 1:1 to watch the intervention video or to watch a stress management video (control), both 7 minutes in duration. Contraceptive methods

2014 American Journal of Obstetrics and Gynecology Controlled trial quality: uncertain

197. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives. (PubMed)

A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives. Does intensive counselling before insertion and throughout the first year of use have any influence on discontinuation rates due to unpredictable menstrual bleeding in users of three long-acting reversible contraceptives (LARCs)?Intensive counselling had a similar effect to routine counselling in terms (...) trial was conducted between 2011 and 2013, and involved 297 women: 98 ENG-implant users, 99 LNG-IUS users and 100 TCu380A IUD users.Women accepting each contraceptive method were randomized into two groups after the women chose their contraceptive method. Group I received routine counselling at the clinic, including information on safety, efficacy and side effects, as well as what to expect regarding bleeding disturbances. Group II received 'intensive counselling'. In addition to the information

Full Text available with Trip Pro

2014 Human reproduction (Oxford, England) Controlled trial quality: uncertain

198. Provision of no-cost, long-acting contraception and teenage pregnancy. (PubMed)

Provision of no-cost, long-acting contraception and teenage pregnancy. The rate of teenage pregnancy in the United States is higher than in other developed nations. Teenage births result in substantial costs, including public assistance, health care costs, and income losses due to lower educational attainment and reduced earning potential.The Contraceptive CHOICE Project was a large prospective cohort study designed to promote the use of long-acting, reversible contraceptive (LARC) methods (...) to reduce unintended pregnancy in the St. Louis region. Participants were educated about reversible contraception, with an emphasis on the benefits of LARC methods, were provided with their choice of reversible contraception at no cost, and were followed for 2 to 3 years. We analyzed pregnancy, birth, and induced-abortion rates among teenage girls and women 15 to 19 years of age in this cohort and compared them with those observed nationally among U.S. teens in the same age group.Of the 1404 teenage

Full Text available with Trip Pro

2014 NEJM

199. The Intrauterine Device in Women of Childbearing Age Has A Greater Long-Term Cost-Benefit than Oral Contraception Pills

the widespread usage of contraception. Improper and inconsistent usage of short acting reversible contraception contributes to the unplanned pregnancy epidemic. Hormonal and copper intrauterine devices are safe and cost-effective alternatives, but usage in the Unites States remains low. Recommended Citation Rogers, Laura, "The Intrauterine Device in Women of Childbearing Age Has A Greater Long-Term Cost-Benefit than Oral Contraception Pills" (2016). School of Physician Assistant Studies . 554. https (...) The Intrauterine Device in Women of Childbearing Age Has A Greater Long-Term Cost-Benefit than Oral Contraception Pills "The Intrauterine Device in Women of Childbearing Age Has A Greater Lon" by Laura Rogers < > > > > > Title Author Date of Graduation Summer 8-13-2016 Degree Type Capstone Project Degree Name Master of Science in Physician Assistant Studies First Advisor Annjanette Sommers, PA-C, MS Rights . Abstract Unplanned pregnancy remains a major problem in the United States, despite

2016 Pacific University EBM Capstone Project

200. Benefits of reversible contraception (PubMed)

Benefits of reversible contraception Long-acting reversible contraception-intrauterine devices and contraceptive implants-offers the highest protection against unintended pregnancies. In addition, the use of reversible hormonal contraception has added health benefits for women in both the short and the long term. This review will give an overview of the benefits of reversible contraception as well as an evidence-based recommendation on how it should be used to benefit women the most.

Full Text available with Trip Pro

2018 F1000Research

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>